International Biotechnology Trust Plc

In our latest monthly blog, we take a look at the many reasons to be positive about the outlook for biotech investors in the years ahead... Following a challenging three years, the biotechnology sector has put in a much more encouraging performance in recent months. Valuations are still attractive, balance sheets look strong and there is an improved funding environment. Read our article to find out more - https://okt.to/oEu49s #biotechnology #investmenttrusts Marketing material. For UK audiences only. Past performance is not a guide to future performance and may not be repeated. Please note forecasts are not a reliable indicator of future results and your capital is at risk with investing.

In our latest monthly blog post, we mark IBT’s 30 year anniversary with a look at the transformation of cancer therapy. As IBT reaches this milestone, the speed of progress in cancer therapy shows no sign of slowing down. Indeed, as we regularly report, the pace of innovation in biotechnology more broadly continues to accelerate. Read article - https://okt.to/SXJ1zr #biotechnology #investmenttrusts Marketing material. For UK audiences only. Past performance is not a guide to future performance and may not be repeated. Please note forecasts are not a reliable indicator of future results and your capital is at risk with investing.

IBT portfolio manager Ailsa Craig joins interactive investor’s latest ‘On the Money’ podcast where she discusses weight-loss drugs, themes she’s favouring in biotech, and why she’s optimistic the sector will bounce back from its worst-ever bear market. Listen here: https://okt.to/3tsayn #biotechnology #podcast #markets Capital at risk. Past performance is not a guide to future performance and may not be repeated. Forecasts are not a reliable indicator for future results. For UK audiences only

In our latest monthly blog post, we explore the implications of global demographics on biotech. The increasingly complex demands of a global population that is growing older, richer and sicker, are driving rising demand for healthcare services in general and underpinning a particularly strong secular growth story in biotechnological innovation. Read more: https://okt.to/DW027i #biotechnology #investmenttrusts Marketing material. For UK audiences only. Past performance is not a guide to future performance and may not be repeated. Please note forecasts are not a reliable indicator of future results and your capital is at risk with investing.

In our latest monthly blog post we explore the changing face of biotechnology. In the UK, investor perceptions of the biotech sector seem outdated. It would perhaps be wrong to say the whole world has moved on, but without doubt, part of it, namely the US biotech sector, has changed beyond recognition over the last 20 years. Read more: https://okt.to/PufKv9 #biotechnology #investmenttrusts Marketing material. For UK audiences only. Past performance is not a guide to future performance and may not be repeated. Please note forecasts are not a reliable indicator of future performance and your capital is at risk with investing.

Biotechnology’s run up since October is more than a flash in the pan. Join International Biotechnology Trust Plc fund managers Ailsa Craig and Marek Poszepczynski at Citywire on 27 February to find out why the sector’s stars are aligning. Details and registration page below.